| The role of MiRNA in cancer: pathogenesis, diagnosis, and treatment E Uzuner, GT Ulu, SB Gürler, Y Baran miRNomics: MicroRNA Biology and Computational Analysis, 375-422, 2022 | 53 | 2022 |
| HER2‐Targeted, Degradable Core Cross‐Linked Micelles for Specific and Dual pH‐Sensitive DOX Release NN Bayram, GT Ulu, M Topuzoğulları, Y Baran, S Dinçer İşoğlu Macromolecular Bioscience 22 (1), 2100375, 2022 | 8 | 2022 |
| Kanser Moleküler Biyolojisi Y Baran, Y Kiraz, GT Ulu Kısayol Yayıncılık, Ankara, 536s, 2018 | 8 | 2018 |
| miRNomics E Uzuner, GT Ulu, SB Gürler, Y Baran | 6 | 2022 |
| Role of Polyunsaturated Fatty Acids in Cancer and Their Use in Cancer Treatment. GT Ulu, Y Kiraz, Y Baran Reviews in Clinical Medicine 6 (3), 2019 | 3 | 2019 |
| Therapeutic potentials of inhibition of Jumonji C domain-containing demethylases in acute myeloid leukemia D Koca, N Hastar, S Engür, Y Kiraz, GT Ulu, D Cekdemir, Y Baran Turkish Journal of Hematology 37 (1), 5, 2020 | 2 | 2020 |
| Personalized biomedicine in cancer: from traditional therapy to sustainable healthcare GT Ulu, Y Kiraz, Y Baran Biodiversity and Biomedicine, 441-457, 2020 | 2 | 2020 |
| Methylation of the transcription factor E2F1 by SETD6 regulates SETD6 expression via a positive feedback mechanism M Kublanovsky, GT Ulu, S Weirich, N Levy, M Feldman, A Jeltsch, D Levy Journal of Biological Chemistry 299 (10), 2023 | 1 | 2023 |
| 3P Determination of therapeutic effects of multifunctional micelle-based nanocarriers on breast cancer cells GT Ulu, NN Bayram, N Abdulhadi, S Gürdap, A İşoğlu, SD İşoğlu, Y Baran Annals of Oncology 32, S1, 2021 | 1 | 2021 |
| Distinct specificities of the HEMK2 protein methyltransferase in methylation of glutamine and lysine residues S Weirich, GT Ulu, TT Chandrasekaran, J Kehl, J Schmid, F Dorscht, ... Protein Science 33 (2), e4897, 2024 | | 2024 |
| E2F1 methylation by SETD6 regulates SETD6 expression via positive feedback mechanism M Kublanovsky, G Ulu, S Weirich, N Levy, M Feldman, A Jeltsch, D Levy bioRxiv, 2023.06. 27.546651, 2023 | | 2023 |
| HER2-specific peptide (LTVSPWY) and antibody (herceptin) targeted core cross-linked micelles for breast cancer: A Comparative study NN Bayram, GT Ulu, NA Abdulhadi, S Gürdap, İA İşoğlu, Y Baran, ... Pharmaceutics 15 (3), 733, 2023 | | 2023 |
| HER2-Specific Peptide (LTVSPWY) and Antibody (Herceptin) Targeted Core Cross-Linked Micelles for Breast Cancer: A Comparative Study. Pharmaceutics 2023, 15, 733 NN Bayram, GT Ulu, NA Abdulhadi, S Gürdap, IA Isoglu, Y Baran, ... | | 2023 |
| Peptıde targeted core cross-lınked mıcelles for dox delıvery to HER2 expressıng cancer cells NN Bayram, GT Ulu, S Gürdap, İA İşoğlu, Y Baran, S Dinçer İşoğlu Mary Ann Liebert, 2022 | | 2022 |
| PEPTIDE TARGETED CORE CROSS-LINKED MICELLES FOR DOX DELIVERY TO HER2 EXPRESSING CANCER CELLS NN Bayram, GT Ulu, S Gurdap, IA Isoglu, Y Baran, SD Isoglu | | 2022 |
| 31P Advantage of co-culture strategy for targeted cancer treatment and in vitro studies GT Ulu, NN Bayram, SD İşoğlu, Y Baran Annals of Oncology 32, S370, 2021 | | 2021 |
| Determination of therapeutic effects of multifunctional micelle-based nanocarriers on breast cancer cells GT Ulu İzmir Institute of Technology, 2019 | | 2019 |
